Orthofix Medical Upgraded to Buy at StockNews.com
| OFIX Stock | USD 12.31 1.46 13.46% |
Slightly above 55% of Orthofix Medical's investors are presently thinking to get in. The analysis of overall sentiment of trading Orthofix Medical stock suggests that some investors are interested at this time. Orthofix Medical's investing sentiment can be driven by a variety of factors including economic data, Orthofix Medical's earnings reports, geopolitical events, and overall market trends.
Orthofix Medical was upgraded by investment analysts at StockNews.com from a hold rating to a buy rating in a research note issued on Tuesday. Other equities research analysts have also recently issued research reports about the company. Roth Mkm reiterated a buy rating and issued a 22.00 price objective up
Read at thelincolnianonline.com
 |
Orthofix Medical Fundamental Analysis
We analyze Orthofix Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orthofix Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orthofix Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Orthofix Medical is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Orthofix Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Orthofix Medical stock to make a market-neutral strategy. Peer analysis of Orthofix Medical could also be used in its relative valuation, which is a method of valuing Orthofix Medical by comparing valuation metrics with similar companies.
Peers
Orthofix Medical Related Equities
| SIBN | Si Bone | 2.93 | ||||
| IART | Integra LifeSciences | 2.03 | ||||
| CNMD | CONMED | 0.04 | ||||
| LUNG | Pulmonx Corp | 0.61 | ||||
| ICUI | ICU Medical | 0.80 | ||||
| MMSI | Merit Medical | 1.04 | ||||
| KIDS | Orthopediatrics Corp | 1.66 |
Additional Tools for Orthofix Stock Analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.